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ABSTRACT
Insertional mutagenesis is a potent forward genetic
screening technique used to identify candidate
cancer genes in mouse model systems. An import-
ant, yet unresolved issue in the analysis of these
screens, is the identification of the genes affected
by the insertions. To address this, we developed
Kernel Convolved Rule Based Mapping (KC-RBM).
KC-RBM exploits distance, orientation and insertion
density across tumors to automatically map integra-
tion sites to target genes. We perform the first
genome-wide evaluation of the association of inser-
tion occurrences with aberrant gene expression of
the predicted targets in both retroviral and trans-
poson data sets. We demonstrate the efficiency of
KC-RBM by showing its superior performance over
existing approaches in recovering true positives
from a list of independently, manually curated
cancer genes. The results of this work will signifi-
cantly enhance the accuracy and speed of cancer
gene discovery in forward genetic screens.
KC-RBM is available as R-package.
INTRODUCTION
Large-scale insertional mutagenesis screens using
retroviruses and transposons are of great importance in
cancer research. By integration into the host DNA,
retroviruses and transposons can mutate the genome.
This process is referred to as insertional mutagenesis.
Insertional mutagenesis can disrupt cellular processes,
alter gene expression and thereby cause cancer. For this
reason, large-scale insertional mutagenesis screens have
been successfully employed to identify new putative
cancer genes, see e.g. (1–5); J. Kool (personal communi-
cation). In addition, retroviral vectors have been shown to
be useful in gene therapy, and transposon-based systems
also show great potential for this same purpose. However,
it is currently still very difﬁcult to predict which surround-
ing genes will be affected by insertions.
To identify potential cancer genes from an insertional
mutagenesis screen, the initial step typically involves the
deﬁnition of common insertion sites (CISs), see e.g.
(1,3,6–9). Insertions are clustered based on inter-insertion-
distance and clusters that are unlikely to occur by chance
are declared CISs. The CISs are then manually
mapped to putative target genes. This manual mapping
could potentially introduce biases. For example,
known cancer genes may be preferred, thus potentially
and unintentionally excluding novel cancer genes. An
additional drawback of this approach is that in deﬁning
CISs, properties of individual insertions, such as dis-
tances to genes and orientation relative to genes are
disregarded.
In contrast, nearest-gene mapping (NGM), maps each
insertion to the nearest gene [e.g. (10)]. While this
approach does operate on individual insertions, and
takes the distance of insertions to genes into account, it
still disregards the relative orientation of insertions, and
does not aggregate insertion data across tumors.
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diate upstream promotor region of a gene is a highly im-
portant modulator of the effect of that insertion on the
gene. More speciﬁcally, if the viral promoter has the same
orientation as the host promoter it can take over its
function (4). For larger upstream and downstream dis-
tances from genes, relative orientation also plays a role:
enhancing insertions are predominantly oriented away
from target genes (4). It is therefore clear that the orien-
tation of an insertion should be taken into account when
determining putative target genes. Furthermore, since the
nearest gene is not necessarily the only or best target gene,
it is important to allow the assignment of multiple target
genes to a single insertion.
To address the issues described above, we developed
Kernel Convolved Rule Based Mapping (KC-RBM).
KC-RBM integrates GKC (7), a method for identifying
statistically signiﬁcant CISs, with rule-based mapping of
individual insertions to genes. Without user intervention,
KC-RBM maps insertions to genes based on
orientation-dependent windows deﬁned around tran-
scripts, and exploits the information contained in the re-
petitive occurrence of insertions at a given locus across
tumors, i.e. CIS information. We perform extensive
analyses of associations between insertion occurrence
and same-sample gene expression to evaluate the param-
eter choices for KC-RBM. We demonstrate the beneﬁts of
KC-RBM in cancer gene discovery through the more
accurate identiﬁcation of target genes from two insertional
mutagenesis screens, a Murine Leukemia Virus (MuLV)
screen and a Sleeping Beauty (SB) transposon screen.
KC-RBM represents the ﬁrst ever approach for mapping
SB transposon insertions to target genes.
MATERIALS AND METHODS
Data sets
Murine Leukemia Virus (MuLV) data. In total 20312
MuLV insertions were extracted from 8 insertional muta-
genesis screens. These screens produced 1020 tumors in
total, and were produced in mice with various genetic
backgrounds (3); J. Kool (personal communication). For
a subset of 1986 insertions in 97 samples (p19 ko, p53 ko,
and wild-type), Illumina MouseWG-6 v2.0 expression
data was available and used.
Sleeping Beauty (SB) transposon data. 58266 SB trans-
poson insertion loci were extracted from 255 lymphomas
collected from T2/Onc2 and Rosa26 SBase mice. For a
subset of 26955 insertions in 135 samples, Illumina
MouseWG-6 v2.0 expression data was available and used.
List of mappings
KC-RBM. Maps insertions to multiple putative target
genes, using four window sizes, one for upstream-sense
insertions one for upstream-antisense insertions, one for
downstream-sense insertions and one for downstream-
antisense insertions (with respect to transcription start
site). Per transcript, these window size parameters are
ﬂexibly applied using two additional parameters, a GKC
scale parameter (7) and a orientation homogeneity param-
eter. A gene is a target gene of an insertion if at least one
of its transcripts is targeted. As an additional step in se-
lecting a single target gene for each insertion, a prioritiza-
tion can be made among the target genes identiﬁed by
KC-RBM according to the number of times they were
targeted by all insertions taken together. Then select the
gene with the highest count to be the single target gene for
that insertion.
Nearest-gene mapping (NGM). For each insertion, ﬁnd
the nearest gene start site, and select this gene to be the
single target gene of that insertion. This method is
compared to KC-RBM.
CIS nearest-gene mapping (CIS-NG). CISs are detected
using GKC (7). The peak of each CIS is then mapped to
its nearest gene start site. This method is compared to
KC-RBM.
Methods
Aligning genes. Figure 1. The set of tumor samples was
reduced to the set for which expression data was available
(n=97). All gene start sites were aligned with respect to
location as well as orientation, and expression values were
z-normalized per gene across samples. For all genes, all
insertions were identiﬁed in a window of 400kb around
these genes. All resulting (relative insertion locus,
z-normalized gene expression) pairs were regarded as
points in the (x,y) plane, and were then binned along the
y-axis, making a distinction between insertions occurring
in sense orientation relative to the gene and in antisense
orientation relative to the gene start site, and normalizing
gene length. The insertion density was computed by
binning the insertions, and computing the number of in-
sertions per base pair for each bin. These values were then
normalized to a scale from 0 to 1.
The inﬂuence of window size. Figure 3. The set of tumor
samples was reduced to the set for which expression data
was available. For each window size value and each gene,
the following approach was taken. Tumor samples were
divided in two groups. The ﬁrst group contained the
samples for which at least one insertion was mapped to
that gene. The second group contained the samples for
which no insertion was mapped to that gene. Between
these two groups, a Wilcoxon-score was computed for
elevated expression in the ﬁrst group. Having computed
this Wilcoxon-score for all genes, a signiﬁcance threshold
was determined per mapping by permuting (n=10000)
gene-wise expression proﬁles across samples with respect
to gene-wise insertion proﬁles across samples, and setting
a 5% signiﬁcance threshold. Per window, each gene with
at least one insertion was classiﬁed as signiﬁcant or not
signiﬁcant exactly once. Per gene, each insertion is
counted only once. Note that when computing the statis-
tics for one of four window sizes, the other window sizes
were set to zero. Furthermore, for all insertions within
transcripts, association of insertion occurrence with
increased expression levels was computed while
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Permutation thresholds (5%) were calculated per
window size.
The inﬂuence of the GKC scale. Figure 4. For each
KC-RBM scale, insertions were mapped to genes, and
numbers and fractions of signiﬁcant genes were
computed as described above. KC-RBM was performed
using window sizes (20kb, 120kb, 40kb, 5kb) (MuLV)
and (20kb, 10kb, 25kb, 5kb) (SB transposon) for
(upstream-sense, upstream-antisense, downstreamsense,
downstream-antisense) insertions, and an orientation
homogeneity fraction of 0.75. For each scale, all insertions
(for MuLV all insertions from screen 1: p19 ko, p53 ko
and wild-type) were mapped to genes, but insertion-
expression association was necessarily only computed for
the samples for which expression data was available.
Comparing KC-RBM, RBM, CIS-NG and CIS-manual
mapping. Figure 5. All insertions were mapped using
KC-RBM, setting the window sizes to (20kb, 120kb,
40kb, 5kb) (MuLV) and (20kb, 10kb, 25kb, 5kb) (SB
transposon) for (upstream-sense, upstream-antisense,
downstream-sense, downstream-antisense) insertions.
The orientation homogeneity fraction was set to 0.75,
and the scale was set to 10kb (MuLV) and 2kb (SB
transposon).
For KC-RBM, lists of top 20 CTGs were obtained by
counting for each gene the number of times it was
targeted, and then sorting this list, based on the number
of times a gene was identiﬁed as a target. Speciﬁcally for
SB transposon insertions, the CTGs were corrected for the
fact that SB transposons only integrate at TA-sites: in
determining CTGs, SB transposon insertions were each
weighted by 1 divided by the local TA-density determined
using the same kernel width as was used for the mapping
of insertions (2kb). The total SB transposon CTG score
across all genes was normalized to be equal to the total
number of insertions. For NGM, also the top 20 CTGs
were determined. CISs were detected using GKC (7), with
a scale of 30kb. The 20 CISs with the highest peaks were
then mapped to their nearest gene start site.
For both the MuLV and the SB transposon data set, the
top 20 results as well as the overall results were compared
to a reference list. For MuLV a manually curated list
based on the same data set exists (4). The complete lists
of genes identiﬁed by the three methods KC-RBM, NGM
and CIS-NG were compared to this manually curated list
(CIS-M) with respect to presence and rank in this list.
Regarding the presence of genes in either of the three
methods in the CIS-M list, the three lists were made the
same size by taking the top N of each list (where N is the
length of the shortest list), to allow for a fair comparison.
For each resulting list, the number of genes in that list also
present in the CIS-M list was counted. For the comparison
between the top two methods, KC-RBM and NGM, sig-
niﬁcance of the difference in numbers present in the
CIS-M list was determined by permutation
(n=100000). Regarding rank, the following steps were
taken. First, all lists were restricted to genes also occurring
in CIS-M. Then, the three lists were made the same size by
selecting only the top N from each list (where N is the
length of the shortest list). This is necessary since the
highest ranking CISs and CTGs are the easiest to
retrieve, which may negatively affect the average rank of
longer lists. Then, for each of the three lists, the average
rank in that list of the genes also present in the manually
curated list was calculated. For the comparison between
the top two methods, KC-RBM and NGM, signiﬁcance of
the difference in average rank was determined by permu-
tation (n=100000).
For the SB transposon insertions a similar approach
was taken, using as a reference the Cancer Gene Census
(11), a list of human cancer-related genes. Mouse
homologs were identiﬁed by mapping the human
EntrezGene identiﬁers to mouse EntrezGene and
Ensembl identiﬁers using the Bioconductor biomaRt
2.2.0 package (12).
RESULTS
Insertion occurrence and gene expression
Since the orientation of an insertion relative to a target
gene and the distance of an insertion to a target gene de-
termine how an insertion may activate that gene, one may
expect association between orientation, distance and gene
expression. Figure 1 depicts an alignment of all genes. A
point represents the average normalized deviation of the
gene expression from the mean as a function of the
distance between a gene and an insertion. A technical ex-
planation of this ﬁgure can be found in the ‘Materials and
Methods’ section. For both the MuLV insertions and the
SB transposon insertions, it can be seen that association of
insertion occurrence with gene expression of nearby genes
is dependent on the distance and orientation of the inser-
tion to the gene.
For MuLV, Figure 1a shows higher average expression
deviation for insertions inside and near genes (demarcated
by the two vertical black lines). There is a clear peak in
expression levels for antisense insertions (red) just
upstream of the gene start site. For sense insertions
(green), a slightly less pronounced peak can be seen just
downstream of the gene start site. These observations are
consistent with mechanisms described in the literature by
which retroviral insertions affect their target genes
(4,5,13). The insertion density across all aligned genes is
plotted in black below the expression values, and demon-
strates an explicit preference of MuLV insertions for loci
near the gene start site, as previously observed (14).
For the SB transposon, Figure 1b suggests that some
association does exist, although much less pronounced
when compared to the retroviral case. Especially for the
sense insertions inside genes there is some elevation in ex-
pression. The insertion density (depicted in black, below
the binned z-values) shows that SB transposon insertions
are predominantly found inside genes.
KC-RBM
Mechanisms described in the literature (4,5,13), supported
by our own observations (Figure 1), suggest that inser-
tions should be mapped to putative target genes using
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transcripts. Depending on the orientation and location of
an insertion, the insertion will fall within or outside
the relevant mapping window. When the insertion falls
within a given window, it will be mapped to the associated
gene. This approach, which we will call rule based
mapping (RBM) is outlined in Figure 2a. It uses four
window size parameters, for upstream-sense, upstream-
antisense, downstream-sense and downstream-antisense
insertions.
The window sizes used by RBM provide strict
boundaries outside of which insertions are not mapped
to a gene. However, as it is presented in Figure 2a,
RBM does not directly exploit the fact that information
from across tumor samples is available. After all, cancer
genes harbor mutations across many independent tumors.
Furthermore, it might be that, in an insertion cluster, a
minority of insertions occur that contradict the window
sizes set for RBM. As an example, consider a cluster of
insertions, a CIS. Suppose that a number of these inser-
tions lie outside the mapping window relative to a certain
gene, and the other insertions lie within the mapping
window. RBM will not map the insertions outside the
mapping window to the gene. However, since the inser-
tions constitute a cluster, it is not unreasonable to assume
that all these insertions will all target the same gene. As
another example, consider again a cluster of insertions.
Let us suppose that a large majority of the insertions
have a sense orientation relative to a target gene, and
just a few insertions are oriented antisense. Here it will
again make sense to map the cluster as a whole to the
same target gene, thereby disregarding the antisense orien-
tation of a small minority of insertions.
The implication of these two examples is that it is
sensible to allow exceptions to the strict application of
the rules, when this is suggested by information regarding
the frequency and orientation of insertions across tumors.
We therefore propose a hybrid approach, involving RBM
and GKC, to exploit information from across tumor
samples to ﬂexibly apply RBM in a data-driven manner.
Recall that GKC (7) detects CISs by estimating the inser-
tion density through a Gaussian kernel convolution and
identifying insertion hot spots based on a random permu-
tation approach. The hybrid approach will be referred to
as KC-RBM, and is illustrated in Figure 2b. First, given
an insertion proﬁle, a Gaussian kernel convolution is
applied to estimate the insertion density, essentially
deﬁning clusters of insertions. Second, all insertions are
associated with their nearest peak. This results in a
number of insertion clusters, one for each peak. Third, if
a cluster is orientation-wise homogeneous enough, all in-
dividual insertions are merged into a single orientation
cluster, otherwise insertions are separated into a sense
and an antisense cluster. The positions of the resulting
clusters are taken to be the average position of the inser-
tions constituting that cluster. Fourth, all clusters mean
loci are mapped using RBM.
In addition to the four window sizes, KC-RBM depends
on two parameters: one for determining the level of
smoothing of the positions of the insertions, and one for
determining the orientation homogeneity of a cluster. The
parameter that determines the smoothing is the standard
Figure 1. Normalized deviation of gene expression from the mean as a function of insertion distance, for (a) MuLV and (b) SB transposon. For all
genes, all insertions are identiﬁed in a window of 500kb around these genes, from the gene start site and from the gene termination site. All genes are
then aligned with respect to location as well as orientation. z-normalized gene expression values are associated with the relative locations of the
insertions within the 500kb window. For all genes and insertions taken together, these expression values are binned, and the distinction is made
between insertions occurring in sense orientation relative to the gene (green) and in antisense orientation relative to the gene (red). The blue line
represents the all insertions taken together. The (aligned) insertion density is plotted in black below the binned z-values. The gene boundaries are
represented by two vertical black lines.
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parameter. The parameter that controls the orientation
homogeneity of a cluster is deﬁned as the minimal
fraction of the insertions constituting a cluster that need
to have the same orientation. The kernel width reﬂects the
degree of strictness with which one wishes to enforce the
mapping window: the smaller the scale, the less ﬂexibility
is allowed in the chosen sizes of the mapping windows.
The orientation homogeneity parameter controls the level
of noise tolerated in the insertion orientation: the higher
the orientation homogeneity fraction, the higher the strin-
gency on the orientation of insertions.
Varying the window sizes
This section explores the inﬂuence of varying the four
window size parameters on insertion–expression associ-
ation, while setting the scale parameter to 0 and the orien-
tation homogeneity parameter to 1.0, i.e. strictly applying
the mapping window widths and without smoothing the
insertion orientation. When compared to the analysis rep-
resented in Figure 1, this analysis is more reﬁned in that
for a particular value of a window size parameter, a
Wilcoxon test is performed to determine whether the
median difference between the expression of samples
with and without a given insertion is signiﬁcantly different
from zero (for more detail, please refer to the ‘Materials
and Methods’ section).
For MuLV, Figure 3a shows the inﬂuence of varying
the window sizes on insertion–expression association, as
measured by the fraction of signiﬁcant associations (true
positive rate) and the number of detected signiﬁcant
associations (number of true positives). In Figure 3a(i),
cases with at least one insertion per gene across samples
were taken into account. The insertions oriented away
from genes, upstream-antisense and downstream-sense,
show the largest association (large fraction of signiﬁcant
genes). This is in concordance with the literature, where
these cases are often denoted as enhancer insertions, and
can activate genes across large distances (4,5,13). In
contrast, the association of upstream-sense insertions is
very local. This is also in concordance with the literature,
where these insertions are often denoted as promoter in-
sertions (4,5,13). Downstream-antisense insertions show
the least association. However, there is a clear association
for small window sizes (<10kb).
In contrast to Figure 3a(i), in Figure 3a(ii) we only
included genes with at least two insertions per gene
across all samples. This shows that, in general, inser-
tion occurrence associates even better with elevated
expression levels, although for small downstream
window sizes (<20kb) the data are very sparse. In both
these ﬁgures the association of downstream antisense in-
sertions is less pronounced than that of downstream sense
insertions.
For the SB transposon, Figure 3b shows the inﬂuence of
different window sizes on insertion–expression associ-
ation. Also in this ﬁgure it is evident that the association
is far less pronounced than for the retroviral case,
although it can be seen that SB transposon insertions
are predominantly found inside genes. Requiring at least
one insertion per gene across samples gives a noisy result
and only shows a slight association for sense insertions.
Requiring at least two insertions (Figure 3b(ii)) gives a
Figure 2. (a) RBM for mapping insertions to genes. Distinctions are made based on three properties. Insertions are distinguished by occurrence
(i) outside or (ii) inside a transcript, upstream or downstream of a transcript, and in sense or antisense orientation with respect to the orientation of
the transcript. (b) KC-RBM for mapping insertions to transcripts. First, given an insertion proﬁle, a Gaussian kernel convolution is applied to
estimate the insertion density. Second, all insertions are associated with their nearest peak. This results in a number of insertion clusters, one for each
peak. Third, if the cluster is orientation-wise homogeneous enough, all individual insertions are merged into a single-orientation cluster, otherwise
insertions are separated into a sense and an antisense cluster. Fourth, all clusters mean loci are mapped using RBM. Finally, a gene is considered a
target of an insertion if at least one of its transcripts is a target.
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cant genes. It shows that the insertion–expression associ-
ation for the SB transposon is far more localized and less
pronounced when compared to retroviral insertions.
Again, the sense insertions associate better with increased
expression. For both downstream-antisense insertions and
downstream-sense insertions, the data are too sparse to
draw meaningful conclusions.
One remark should be made on the visual presentation
in Figure 3. To allow for a 2D presentation, the four
window types and the within-transcript case are treated
separately. i.e. when computing the statistic for one
speciﬁc window size, the other three are set to zero. A
more comprehensive view is offered in a more complex
4D visualization in the Supplementary Data (Supple-
mentary Figures S7, S8, S11 and S12), but does not lead
to different observations.
Varying the smoothing
This section explores the inﬂuence of varying the Gaussian
Kernel Convolution scale parameter on insertion–expres-
sion association, while keeping the orientation homogen-
eity parameter and the four window sizes constant.
Figure 3 showed there are substantial differences in
strength of insertion–expression association for the four
window size parameters. Therefore, while varying the
smoothing, these window sizes are ﬁxed to values reﬂect-
ing this relative strength of insertion–expression associ-
ation. This implies that the upstream-antisense window
(ua) is the largest window, followed by the downstream-
sense (ds) window, the upstream-sense (us) window and
the downstream-antisense (da) window, respectively.
Furthermore, window sizes are chosen such that the
fraction of signiﬁcant genes never falls below the permu-
tation threshold of 5%, and a particular window size is
Figure 3. The inﬂuence of the four window sizes on mapping quality for (a) MuLV and (b) the SB transposon, for requiring (i) at least one insertion
per gene across samples, (ii) at least two insertions per gene across samples or (iii) at least three insertions per gene across samples. A distinction is
made between upstream-sense, upstream-antisense, downstream-sense, and downstream-antisense windows. For an explanation of the computation
of the fractions and numbers of signiﬁcant genes (true positive rate and number of true positives, respectively) refer to the ‘Materials and Methods’
section. First, computation is done for multiple window sizes. Second, when computing the statistics for one of four window sizes, the other window
sizes are set to zero. Third, for all insertions within transcripts association of insertion occurrence with increased expression levels was computed
while disregarding the insertions outside transcripts. Permutation thresholds (5%, represented by the dotted black line) were calculated per window
size.
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that window. This resulted in the window sizes (us, ua, ds,
da)=(20kb, 120kb, 40kb, 5kb). Furthermore the orien-
tation homogeneity minimal fraction was set to 0.75.
For these parameter values, the inﬂuence of the scale
parameter on the number of signiﬁcant genes and the
fraction of signiﬁcant genes is visualized in Figure 4. For
the MuLV data set, KC-RBM achieves stronger associ-
ations if smoothing is applied, for all scales larger than
5kb, and especially for scales around 10kb and 35kb
(Figure 4a). For scales larger than 35kb the performance
deteriorates, with the number of signiﬁcant genes
increasing and the fraction of signiﬁcant genes decreasing.
For the SB transposon, Figure 4b again shows that the
association of SB transposon insertions with increased
gene expression is less pronounced than in the case of
MuLV. However, the strongest association is attained
for small scales around 2kb. Furthermore, similar to the
retroviral case, the number and fraction of signiﬁcant
genes diverges for larger scales. Hence, we ﬁxed the the
kernel width for MuLV at 10kb and for the SB trans-
poson at 2kb.
Using KC-RBM for cancer gene identiﬁcation
In previous sections, we have investigated how the associ-
ation between insertion presence and gene expression is
modulated by the parameters of KC-RBM (window
sizes and kernel width for a ﬁxed homogeneity parameter),
and ﬁxed these parameters to appropriate values. Now, we
will demonstrate how KC-RBM is employed for the iden-
tiﬁcation of cancer genes based on the insertion data only.
Recall that for each insertion, KC-RBM identiﬁes a list
of putative target genes. However, for a given insertion,
not all identiﬁed targets may be of equal importance. As a
ﬁrst step in extracting interesting genes from a KC-RBM
mapping, we will select at most a single target for each
insertion. More speciﬁcally, among the targets identiﬁed
per insertion, we rank the genes according to the number
of times they were targeted across insertions, and select the
top ranking gene as the single target for that insertion.
This selects for genes frequently targeted across insertions.
The set of all targeted genes can subsequently be ranked
by counting for each gene the number of times that gene
was targeted by an insertion, resulting in a list of
commonly targeted genes (CTGs).
Figure 5a shows a top 20 CTG list for the MuLV data
set, obtained by applying the procedure described above.
Figure 5d shows the results for the SB transposon data set.
Evaluating KC-RBM
In this section, we will evaluate the effectiveness of
KC-RBM in identifying cancer genes by following the
steps described in the previous section, and comparing
the results obtained with two other methods for compu-
tationally identifying cancer genes from insertional muta-
genesis screens. The ﬁrst method performs a GKC-based
CIS analysis (7), and then maps each CIS peak to the
nearest gene. We will refer to this method as
CIS-nearest-gene mapping (CIS-NG). The second
method consists of mapping each insertion to the nearest
gene, and then determining the CTGs. We will refer to this
method as NGM. The results obtained by these three
methods will be evaluated by comparing them to
manually curated lists of cancer genes.
For MuLV, a manually curated list exists, based on a
subset of the same MuLV insertion data (3). In Figure 5b
Figure 4. The inﬂuence of the GKC scale parameter on the number of true positives and the true positive rate, for performing RBM on
(a) the MuLV data and (b) the SB transposon data using window sizes (20kb, 120kb, 40kb, 5kb) (MuLV) and (20kb, 10kb, 25kb, 5kb)
(SB transposon) for (upstream-sense, upstream-antisense, downstream-sense, downstream-antisense) insertions. The orientation homogeneity
parameter was set to 0.75.
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compared to the top 20 lists for KC-RBM, NGM and
CIS-NG mapping. The seven genes identiﬁed in all three
mappings were also present in the manually curated list.
With the exception of Med20, all genes in the KC-RBM
lists were identiﬁed in the manually curated list as well.
The presence of Med20 is explained by its proximity to
Ccnd3. In the manually curated list, the insertions in the
neighborhood of Med20 were mapped to Ccnd3. CIS-NG
ﬁnds two targets neither of which were present in the other
two mappings nor in the manually curated list. These two
genes, Gm10125 and Fgd2, lie near Zhfx1a (Zeb1) and
Pim1, respectively, which are present in the manually
curated list. NGM ﬁnds three targets neither identiﬁed
in the other two mapping nor in the manually curated
list, Gm10826, Al672278.1 and Evi5. These genes lie near
Myb, Runx1 and Gﬁ1, respectively, which were identiﬁed
in the manually curated list as the target genes of corres-
ponding CISs.
For MuLV, the lists of CTGs are also more extensively
compared in Figure 5c, not restricting the comparison to
only the top 20 CTGs, and again taking the manually
curated list as a reference. This shows that, of all three
methods, KC-RBM identiﬁes the largest number of genes
present in the manually curated list. The difference in the
number of genes identiﬁed by KC-RBM and the
second-best method, NGM, is highly signiﬁcant
(P<10
5, based on a permutation approach).
Furthermore, the genes identiﬁed by KC-RBM that were
also identiﬁed in the manually curated list, rank higher
(lower average rank in the KC-RBM list), when
compared to the other methods. The difference in rank
between KC-RBM and the second-best method, NGM,
is also highly signiﬁcant (P<10
5, based on a permuta-
tion approach)
Figure 5. Comparison between genes identiﬁed by CTG mapping and by CIS mapping for MuLV and SB transposon. The top 20 CTGs identiﬁed
by KC-RBM for (a) MuLV and (d) SB transposon; on the x-axis the gene symbol, on the y-axis the number of times a certain gene was identiﬁed as
a target. KC-RBM was performed using window sizes (20kb, 120kb, 40kb, 5kb) for the MuLV data and (20kb, 10kb, 25kb, 5kb) for the SB
transposon data, for upstream-sense, upstream-antisense, downstream-sense and downstream-antisense windows, respectively. The scale parameters
were set to 10kb (MuLV) and 2kb (SB transposon). The orientation homogeneity parameter in both cases was set to 0.75. Venn diagrams for both
(b) MuLV and (e) SB transposon depicting the overlap between the top 20 CTGs identiﬁed by KC-RBM-CTG mapping, and the top 20
CIS-nearest-genes. Gene names in bold face refer to genes that were also identiﬁed in the manually curated list of 346 CISs (3) (MuLV) or in
the Cancer Gene Census (SB transposon). For (c) MuLV and (f) SB transposon, the complete lists of CTGs are also more extensively compared to
the manually curated set (MuLV) and the Cancer Gene Census list (B transposon), again taking the manually curated list as a reference. This shows
that KC-RBM performs better than both CIS-NG and NGM.
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insertions. Therefore, the Cancer Gene Census (11) was
taken as a reference for evaluating the targets identiﬁed
by the three approaches based on this data set. The results
of the comparison of KC-RBM, NGM and CIS-NG
mapping are depicted in Figure 5. Four genes are
present in all three mappings, Erg, Pten, Notch1 and
Nr3c1. All these genes are known cancer-related genes,
see e.g. (15–18), and the ﬁrst three are also present in
the Cancer Gene Census. NGM is the only approach
that identiﬁes Kit as an additional Cancer Gene Census
gene. Both CIS-NG and KC-RBM identify Akt2 in
addition to the Cancer Gene Census jointly detected by
all three approaches. However, KC-RBM ﬁnds eight add-
itional Cancer Gene Census genes. Similar to the retro-
viral case, somewhat more obscure proximal targets can
score very high in CIS-NG mapping and NGM. Examples
are AC153556.1, RP23-336G7.3 and RP23-24E11.3, which
are located in the vicinity of Myb, Jak1 and Bach2, re-
spectively. Myb, Jak1 and Bach2 are identiﬁed exclusively
by KC-RBM and have been shown to be involved in
cancer, see e.g. (19–21).
The results in Figure 5e are further substantiated by the
more extensive comparison in Figure 5c, comparing larger
lists of genes (refer to the ‘Materials and Methods’
section), and again taking the Cancer Gene Census as a
reference. KC-RBM again performs best in terms of the
average rank of the Cancer Gene Census genes it identiﬁes
as well as the number of Cancer Gene Census genes
identiﬁed. Furthermore, the differences in presence and
rank between KC-RBM and the second-best method
(CIS-NG in this case), are again signiﬁcant (P=0.016
and P=0.039, respectively). Note that the Cancer Gene
Census is less relevant for the SB insertion data than the
manually curated list is for the MuLV data. It is not based
on a SB transposon insertional mutagenesis screen.
Furthermore, it is a list of human genes, which addition-
ally have to be mapped to mouse homologs.
Consequently, the overlap between the genes identiﬁed
by the three methods and the Cancer Gene Census genes
is much smaller compared to the MuLV case, resulting in
higher P-values. Nevertheless, the P-values are signiﬁcant,
and demonstrate clearly that KC-RBM retrieves more
cancer-related genes than the other methods.
DISCUSSION
In this article, we presented KC-RBM, a method for auto-
matically mapping individual retroviral and SB trans-
poson insertions to putative target genes. KC-RBM
represents the ﬁrst ever approach for mapping SB trans-
poson insertions to target genes. In addition, the analyses
presented here constitute the ﬁrst genome-wide analysis of
insertion and same-sample gene expression for retro-
viruses and transposons. Such a comprehensive data set
provides signiﬁcant power in determining the factors that
govern the associations between insertions and neighbor-
ing genes.
It is important to emphasize that, while mapping indi-
vidual insertions to target genes, KC-RBM also exploits
cross-sample information in multiple ways. The KC-RBM
scale parameter allows for smoothing the positions of in-
sertions based on cross-sample information. The insertion
orientations are smoothed based on cross-sample informa-
tion by setting the orientation homogeneity fraction par-
ameter in KC-RBM. Furthermore, determining CTGs by
aggregating insertions also integrates information from
across tumor samples.
Although the presence of insertions is associated with
increased gene expression (Figure 1) the analysis presented
in Figure 1 does not provide sufﬁcient evidence to distin-
guish cause from effect. In other words, we cannot
conclude from this associative analysis that the presence
of an insertion causes higher or lower gene expression. It is
certainly possible that insertions are more likely to occur
in actively transcribed regions, i.e. near genes with
elevated expression levels. This and other factors
inducing insertion biases have, in fact, been demonstrated
for retroviruses as well as for transposons, e.g. (14,22–28).
However, regardless of the determinants of insertion bias,
it is a fact that insertions cause tumors since there is a
statistically signiﬁcant increase in the tumor incidence in
animals infected with MuLV or in animals where SB
transposons are activated (3,29). It is therefore very
likely that these insertions caused, among other, changes
in gene expression that resulted in oncogenesis. To further
explore the causal relationship between insertions and
aberrant gene expression, we performed additional
analyses, the results of which are presented in the
Supplementary Data.
The ﬁrst analysis involves the distribution of insertion
orientation in CTGs. If insertions were simply occurring
in regions that were already transcriptionally active, i.e.
elevated expression being the cause of insertions, one
would expect insertions in these regions to show no pref-
erence for orientation. On the other hand, if the insertions
were the cause of elevated gene expression, one would
expect a strong preference for an orientation consistent
with activation of the target gene(s). To test this hypoth-
esis, we performed two tests. First, we randomized the
insertion orientation in both the MuLV and SB data sets
and regenerated the expression–position–orientation plots
as presented in Figure 1. As can be seen in Supplementary
Figures S2 and S10, the orientation-dependent effect on
gene expression disappears. Second, we analyzed the
orientation distribution of insertions assigned to the top
214 MuLV CTGs (only including CTGs with 10 or more
insertions). The results show a highly signiﬁcant prefer-
ence for orientation, consistent with the known mechan-
isms employed by retroviruses to activate target genes
(see Supplementary Figures S3 and S4). Strong prefer-
ences for activating orientations were also established
for the SB transposon (Supplementary Figure S13). To
further explore the causal relationship between insertions
and gene expression, we performed a second analysis
where we compared expression data from normal and
tumor tissue. If insertions would simply target genes that
are already active in normal tissue, there will be little dif-
ference between the activity of genes carrying insertions in
tumor tissue and the activity of these same genes in
normal tissue. To test this hypothesis, we compared gene
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sion of these same genes in normal tissue. For the cancer
tissue, only tumors with insertions in a speciﬁc CTG were
included in the analysis. These analyses showed that in the
cases where the average expression was higher in the
cancer tissue compared to normal tissue, the increase
was signiﬁcant in 84.2% of the cases. This implies that
in the vast majority of cases a gene carrying an insertion
in the tumor tissue was signiﬁcantly differentially ex-
pressed with respect to that same gene in normal tissue.
For the cases where the average expression was lower in
the tumor tissue with respect to normal tissue, the decrease
was signiﬁcant in 72.7% of the cases (see Supplementary
Figure S5). This strongly suggests that frequently targeted
genes showing aberrant expression in tumor tissue, are not
already active in normal tissue, hence challenging the
aforementioned hypothesis that insertions simply tend to
insert in genes that are already active in normal tissue.
Taken together, the strong orientation preference and
the strong association of insertion presence with a change
in gene expression suggest that a large fraction of inser-
tions play a causal role in aberrant gene expression in
tumor samples. Lastly and perhaps most importantly, it
should be emphasized that while we employed the associ-
ation of insertions and gene expression to obtain settings
of the four window sizes in KC-RBM, this is not a require-
ment for the approach. In fact, depending on a research-
er’s interests, different window sizes may be appropriate.
As the deﬁnitive test for the performance of KC-RBM,
and regardless of the direction of causality, we evaluated
its ability to identify known cancer-associated genes from
a manually curated list (3), and from the Cancer Gene
Census (11). KC-RBM gives superior results when
compared to automated CIS-NG mapping and NGM.
Without the need for human intervention, it avoids
more obscure proximal targets and ﬁnds a clean list of
well-known cancer-related genes, as demonstrated by the
comparison with a manually curated list (3), and the
Cancer Gene Census (11). This is important, since
human interference could cause a bias, for example
toward known or expected cancer genes, thus actually pre-
venting the discovery of new or unknown cancer genes.
This emphasizes the added value that a reliable automated
insertion mapping procedure such as KC-RBM can have
for analyzing insertional mutagenesis data and discovering
novel oncogenes and tumor suppressor genes. As such, we
believe that KC-RBM will signiﬁcantly increase the efﬁ-
ciency of cancer gene discovery from insertional mutagen-
esis screens.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
This work was ﬁnanced by the Netherlands
Consortium for Systems Biology (NCSB) which is part
of the Netherlands Genomics Initiative/Netherlands
Organisation for Scientiﬁc Research. David J. Adams is
supported by Cancer Research UK and the Wellcome
Trust. Funding for open access charge: The Netherlands
Consortium for Systems.
Conﬂict of interest statement. None declared.
REFERENCES
1. Mikkers,H., Allen,J., Knipscheer,P., Romeijn,L., Hart,A., Vink,E.,
Berns,A. and Romeyn,L. (2002) High-throughput retroviral
tagging to identify components of speciﬁc signaling pathways
in cancer. Nat. Genet., 32, 153–159.
2. Lund,A., Turner,G., Trubetskoy,A., Verhoeven,E., Wientjens,E.,
Hulsman,D., Russell,R., DePinho,R., Lenz,J. and
van Lohuizen,M. (2002) Genome-wide retroviral insertional
tagging of genes involved in cancer in Cdkn2a-deﬁcient mice.
Nat. Genet., 32, 160–165.
3. Uren,A., Kool,J., Matentzoglu,K., deRidder,J., Mattison,J.,
van Uitert,M., Lagcher,W., Sie,D., Tanger,E., Cox,T. et al. (2008)
Large-scale mutagenesis in p19(ARF)- and p53-deﬁcient mice
identiﬁes cancer genes and their collaborative networks. Cell, 133,
727–741.
4. Uren,A., Kool,J., Berns,A. and van Lohuizen,M. (2005)
Retroviral insertional mutagenesis: past, present and future.
Oncogene, 24, 7656–7672.
5. Kool,J. and Berns,A. (2009) High-throughput insertional
mutagenesis screens in mice to identify oncogenic networks.
Nat. Rev. Cancer., 9, 389–399.
6. Suzuki,T., Shen,H., Akagi,K., Morse,H.C., Malley,J., Naiman,D.,
Jenkins,N. and Copeland,N. (2002) New genes involved in cancer
identiﬁed by retroviral tagging. Nat. Genet., 32, 166–174.
7. deRidder,J., Uren,A., Kool,J., Reinders,M. and Wessels,L. (2006)
Detecting statistically signiﬁcant common insertion sites in
retroviral insertional mutagenesis screens. PLoS Comput. Biol., 2,
1530–1542.
8. Sauvageau,M., Miller,M., Lemieux,S., Lessard,J., He ´ bert,J. and
Sauvageau,G. (2008) Quantitative expression proﬁling guided by
common retroviral insertion sites reveals novel and cell type
speciﬁc cancer genes in leukemia. Blood, 111, 790–799.
9. Mattison,J., Kool,J., Uren,A., deRidder,J., Wessels,L., Jonkers,J.,
Bignell,G., Butler,A., Rust,A., Brosch,M. et al. (2010) Novel
candidate cancer genes identiﬁed by a large-scale cross-species
comparative oncogenomics approach. Cancer Res., 70, 883–895.
10. Erkeland,S., Verhaak,R., Valk,P., Delwel,R., Lowenberg,B. and
Touw,I. (2006) Signiﬁcance of murine retroviral mutagenesis for
identiﬁcation of disease genes in human acute myeloid leukemia.
Cancer Res., 66, 622–626.
11. Futreal,P., Coin,L., Marshall,M., Down,T., Hubbard,T.,
Wooster,R., Rahman,N. and Stratton,M. (2004) A census of
human cancer genes. Nat. Rev. Cancer, 4, 177–183.
12. Durinck,S., Moreau,Y., Kasprzyk,A., Davis,S., De Moor,B.,
Brazma,A. and Huber,W. (2005) BioMart and bioconductor: a
powerful link between biological databases and microarray data
analysis. Bioinformatics, 21, 3439–3440.
13. Jonkers,J. and Berns,A. (1996) Retroviral insertional mutagenesis
as a strategy to identify cancer genes. Biochim. Biophys. Acta.,
1287, 29–57.
14. Wu,X., Li,Y., Crise,B. and Burgess,S. (2003) Transcription start
regions in the human genome are favored targets for MLV
integration. Science, 300, 1749–1751.
15. Sashida,G., Bazzoli,E., Menendez,S., Liu,Y. and Nimer,S. (2010)
The oncogenic role of the ETS transcription factors MEF and
ERG. Cell Cycle, 9, 3457–3459.
16. Salmena,L., Carracedo,A. and Pandolﬁ,P. (2008) Tenets of PTEN
tumor suppression. Cell, 133, 403–414.
17. Allenspach,E., Maillard,I., Aster,J. and Pear,W. (2002) Notch
signaling in cancer. Cancer Biol. Ther., 1, 466–476.
18. Lind,G., Kleivi,K., Meling,G., Teixeira,M., Thiis-Evensen,E.,
Rognum,T. and Lothe,R. (2006) ADAMTS1, CRABP1, and
NR3C1 identiﬁed as epigenetically deregulated genes in colorectal
tumorigenesis. Cell Oncol., 28, 259–272.
e105 Nucleic Acids Research, 2011,Vol.39, No. 15 PAGE 10 OF 1119. Ramsay,R. and Gonda,T. (2008) MYB function in normal and
cancer cells. Nat. Rev. Cancer, 8, 523–534.
20. Ono,A., Kono,K., Ikebe,D., Muto,A., Sun,J., Kobayashi,M.,
Ueda,K., Melo,J., Igarashi,K. and Tashiro,S. (2007) Nuclear
positioning of the BACH2 gene in BCR-ABL positive leukemic
cells. Gene. Chromosome. Canc., 46, 67–74.
21. Verma,A., Kambhampati,S., Parmar,S. and Platanias,L. (2003)
Jak family of kinases in cancer. Cancer Metast. Rev., 22,
423–434.
22. Berry,C., Hannenhalli,S., Leipzig,J. and Bushman,F. (2006)
Selection of target sites for mobile DNA integration in the
human genome. PLoS Comput. Biol., 2, e157.
23. Hematti,P., Hong,B., Ferguson,C., Adler,R., Hanawa,H.,
Sellers,S., Holt,I., Eckfeldt,C., Sharma,Y., Schmidt,M. et al.
(2004) Distinct genomic integration of MLV and SIV vectors in
primate hematopoietic stem and progenitor cells. PLoS Biol., 2,
2183–2190.
24. Mitchell,R., Beitzel,B., Schroder,A., Shinn,P., Chen,H., Berry,C.,
Ecker,J. and Bushman,F. (2004) Retroviral DNA integration:
ASLV, HIV and MLV show distinct target site preferences.
PLoS Biol., 2, e234.
25. Bushman,F., Lewinski,M., Ciufﬁ,A., Barr,S., Leipzig,J.,
Hannenhalli,S. and Hoffmann,C. (2005) Genome-wide analysis of
retroviral DNA integration. Nat. Rev. Microbiol., 3, 848–58.
26. Lewinski,M., Yamashita,M., Emerman,M., Ciufﬁ,A., Marshall,H.,
Crawford,G., Collins,F., Shinn,P., Leipzig,J., Hannenhalli,S. et al.
(2006) Retroviral DNA integration: viral and cellular
determinants of target-site selection. PLoS Pathog., 2.
27. Ambrosi,A., Cattoglio,C. and Di Serio,C. (2008) Retroviral
integration process in the human genome: Is it really
non-random? A new statistical approach. PLoS Comput. Biol., 4,
e1000144.
28. Plachy,J., Kota ´ b,J., Divina,P., Reinisova,M., Senigl,F. and
Hejnar,J. (2010) Proviruses selected for high and stable expression
of transduced genes accumulate in broadly transcribed genome
areas. J. Virol., 84, 4204–4211.
29. Starr,T., Allaei,R., Silverstein,K., Staggs,R., Sarver,A.,
Bergemann,T., Gupta,M., Gerard O’Sullivan,M., Matise,I.,
Dupuy,A. et al. (2009) A Transposon-Based genetic screen in
mice identiﬁes genes altered in colorectal cancer. Science, 323,
1747–1750.
PAGE 11 OF 11 Nucleic Acids Research, 2011,Vol.39, No. 15 e105